“PoNS Therapy’s neuromodulation effect on brain mechanisms of motor control is likely to enhance neuroplasticity and contribute to maintain PoNS therapeutic effect on gait deficit in people ...

Furthermore, the company is preparing for FDA submission for stroke authorization, and is exploring the expansion of PoNS therapy for traumatic brain injury patients. Despite facing a revenue ...

The inner regions of the brain closer to incoming blood flow (pons/medulla, thalamus, and hypothalamus) contained consistently higher concentrations of perfluorooctane sulfonate (PFOS) and several ...

“Gait and balance deficits are the most frequently occurring disability in stroke patients and represent the largest market opportunity for PoNS Therapy ®,” said Dane Andreeff, Helius Medical ...